New report for World Market for Orthopedic by Kalorama Information
04 Jan 2012 • by Natalie Aster
Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fracture to facilitate healing or to compensate for a lack or loss of bone tissue. Biomaterials used in orthopedic surgery include autografts, allografts, xenografts, ceramics, polymers, bone growth factors and synovial fluid substitutes. Among the prominent applications for orthopedic biomaterials are surface coatings for hip prostheses, bone cements, bone defect fillers, and fracture fixation plates.
According to the report “Orthopedic Biomaterials, The World Market” by Kalorama Information, the orthopedic biomaterials market represents 14% of the global orthopedics market, or about $5.8 billion in 2010, with double digit annual growth expected through 2016.
Orthopedic Biomaterials, The World Market
Published: May, 2011
Price: US$ 3.995,00
Musculoskeletal conditions are the most common cause of chronic disability. These conditions comprise over 150 diseases and syndromes, which are usually progressive and associated with pain. They can broadly be categorized as joint diseases, physical disabilities, spinal disorders, and conditions resulting from trauma. Those conditions with the greatest impact on society include rheumatoid arthritis, osteoarthritis, osteoporosis, lower back pain, and limb trauma. Approximately 2 million bone-grafting procedures in the spine, extremities and pelvis are performed each year on a worldwide basis.
More information can be found in the report “Orthopedic Biomaterials, The World Market” by Kalorama Information.
To order the report or ask for sample pages contact [email protected]